Aberrant expression of polo‑like kinase 4 in renal cell carcinoma: Association with clinicopathological characteristics and long‑term survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aberrant expression of polo‑like kinase 4 in renal cell carcinoma: Association with clinicopathological characteristics and long‑term survival

Published:2022-10-14 Issue:6 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Jiang Wenxia¹,Zhao Yan²,Zhang Suxia³,Zeng Yu³,Ma Jun⁴

Affiliation:

1. School of Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China

2. Experimental Centre of Medicine and Life Science, Tongji University, Shanghai 200331, P.R. China

3. Department of Pathology, Tongji Hospital of Tongji University, Shanghai 200065, P.R. China

4. Department of Nephrology, Jing'an District Center Hospital of Shanghai, Fudan University, Shanghai 200040, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference34 articles.

1. Renal cell carcinoma: Diagnosis and management;Gray;Am Fam Physician,2019

2. Epidemiology of renal cell carcinoma;Padala;World J Oncol,2020

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

4. Cancer incidence and mortality of kidney and unspecified urinary organs in China, 2015;Chen;Zhonghua Zhong Liu Za Zhi,2020

5. Computational identification and analysis of early diagnostic biomarkers for kidney cancer;Tang;J Hum Genet,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLK4 Reflects Extrathyroidal Invasion, High Tumor Stage And Poor Prognosis in Papillary Thyroid Carcinoma Patients;Biomarkers in Medicine;2024-03

2. Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection;BMC Women's Health;2024-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3